Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin.

Jouvenet N, Neil SJ, Zhadina M, Zang T, Kratovac Z, Lee Y, McNatt M, Hatziioannou T, Bieniasz PD.

J Virol. 2009 Feb;83(4):1837-44. doi: 10.1128/JVI.02211-08. Epub 2008 Nov 26.

2.

Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P.

Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2886-91. doi: 10.1073/pnas.0811014106. Epub 2009 Jan 28.

3.

Inhibition of virus-like particle release of Sendai virus and Nipah virus, but not that of mumps virus, by tetherin/CD317/BST-2.

Kong WS, Irie T, Yoshida A, Kawabata R, Kadoi T, Sakaguchi T.

Hiroshima J Med Sci. 2012 Sep;61(3):59-67.

PMID:
23077864
4.

Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.

Dietrich I, McMonagle EL, Petit SJ, Vijayakrishnan S, Logan N, Chan CN, Towers GJ, Hosie MJ, Willett BJ.

J Virol. 2011 Jun;85(12):5840-52. doi: 10.1128/JVI.00071-11. Epub 2011 Apr 13.

5.

Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.

Le Tortorec A, Neil SJ.

J Virol. 2009 Nov;83(22):11966-78. doi: 10.1128/JVI.01515-09. Epub 2009 Sep 9.

6.

Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.

McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, Johnson WE, Neil SJ, Bieniasz PD.

PLoS Pathog. 2009 Feb;5(2):e1000300. doi: 10.1371/journal.ppat.1000300. Epub 2009 Feb 13.

7.

The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.

Yan R, Zhao X, Cai D, Liu Y, Block TM, Guo JT, Guo H.

J Virol. 2015 Sep;89(18):9200-12. doi: 10.1128/JVI.00933-15. Epub 2015 Jun 24.

8.

Host factors involved in retroviral budding and release.

Martin-Serrano J, Neil SJ.

Nat Rev Microbiol. 2011 Jun 16;9(7):519-31. doi: 10.1038/nrmicro2596. Review.

PMID:
21677686
9.

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.

Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana IB, Johnson WE, Westmoreland S, Evans DT.

PLoS Pathog. 2009 May;5(5):e1000429. doi: 10.1371/journal.ppat.1000429. Epub 2009 May 15.

10.
11.

Influenza virus partially counteracts restriction imposed by tetherin/BST-2.

Mangeat B, Cavagliotti L, Lehmann M, Gers-Huber G, Kaur I, Thomas Y, Kaiser L, Piguet V.

J Biol Chem. 2012 Jun 22;287(26):22015-29. doi: 10.1074/jbc.M111.319996. Epub 2012 Apr 6.

12.

Tetherin restricts direct cell-to-cell infection of HIV-1.

Kuhl BD, Sloan RD, Donahue DA, Bar-Magen T, Liang C, Wainberg MA.

Retrovirology. 2010 Dec 24;7:115. doi: 10.1186/1742-4690-7-115.

13.

Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.

Lopez LA, Yang SJ, Hauser H, Exline CM, Haworth KG, Oldenburg J, Cannon PM.

J Virol. 2010 Jul;84(14):7243-55. doi: 10.1128/JVI.02636-09. Epub 2010 May 5.

14.

CAML does not modulate tetherin-mediated restriction of HIV-1 particle release.

Ali MS, Hammonds J, Ding L, Spearman P.

PLoS One. 2010 Feb 2;5(2):e9005. doi: 10.1371/journal.pone.0009005.

15.

Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin.

Radoshitzky SR, Dong L, Chi X, Clester JC, Retterer C, Spurgers K, Kuhn JH, Sandwick S, Ruthel G, Kota K, Boltz D, Warren T, Kranzusch PJ, Whelan SP, Bavari S.

J Virol. 2010 Oct;84(20):10569-80. doi: 10.1128/JVI.00103-10. Epub 2010 Aug 4.

16.

Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.

Lopez LA, Yang SJ, Exline CM, Rengarajan S, Haworth KG, Cannon PM.

J Virol. 2012 May;86(10):5467-80. doi: 10.1128/JVI.06280-11. Epub 2012 Mar 7.

17.

BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction.

Miyakawa K, Ryo A, Murakami T, Ohba K, Yamaoka S, Fukuda M, Guatelli J, Yamamoto N.

PLoS Pathog. 2009 Dec;5(12):e1000700. doi: 10.1371/journal.ppat.1000700. Epub 2009 Dec 18.

18.

Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.

Goffinet C, Schmidt S, Kern C, Oberbremer L, Keppler OT.

J Virol. 2010 Nov;84(21):11374-84. doi: 10.1128/JVI.01067-10. Epub 2010 Aug 11.

19.

Emerging role of the host restriction factor tetherin in viral immune sensing.

Hotter D, Sauter D, Kirchhoff F.

J Mol Biol. 2013 Dec 13;425(24):4956-64. doi: 10.1016/j.jmb.2013.09.029. Epub 2013 Sep 26. Review.

PMID:
24075872
20.

Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.

Lv M, Wang J, Wang X, Zuo T, Zhu Y, Kong W, Yu X.

PLoS One. 2011;6(6):e20890. doi: 10.1371/journal.pone.0020890. Epub 2011 Jun 2.

Supplemental Content

Support Center